Product Program year 2025 Source: CMS Open Payments

Orencia

Biological Immunology

NDC 0003-2187-10

Open in the dashboard

General payments

$3,042,858

62,524 payments

Research payments

$76,702,580

914 payments

Through program year 2025, $3,042,858 in general payments and $76,702,580 in research payments were reported against Orencia (Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $207,305 10,418
2025 Research $9,469,025 43
2024 General $173,843 8,600
2024 Research $14,045,927 83
2023 General $86,509 3,573
2023 Research $10,435,749 82
2022 General $293,345 4,043
2022 Research $11,949,598 155
2021 General $488,876 12,196
2021 Research $10,056,050 173
2020 General $617,715 9,319
2020 Research $9,975,729 191
2019 General $1,175,264 14,375
2019 Research $10,770,502 187

Breakdown

Who paid General payments · program years 2019–2025
  1. E.R. Squibb & Sons, L.L.C. $3,038,484 62,292 payments
  2. Celgene Corporation $4,374 232 payments
Top recipients General payments · program year 2025
  1. Langley Porter Psychiatric Hospital Teaching hospital · CA $4,500 2% · 1 payment
  2. U Of U Hospitals & Clinics Teaching hospital · UT $3,000 1% · 1 payment
  3. Metrohealth Medical Center Teaching hospital · OH $2,000 <1% · 1 payment
  4. University Of Alabama Hospital Teaching hospital · AL $2,000 <1% · 2 payments
  5. Iris Zink Nurse Practitioner, Family · Lansing, MI $616 <1% · 18 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Rheumatology Internal Medicine $117,896 62% · 1,489 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $21,621 11% · 243 practitioners
  3. Physician Assistant $18,432 10% · 233 practitioners
  4. Nurse Practitioner $11,899 6% · 129 practitioners
  5. Physician Assistant, Medical Physician Assistant $7,348 4% · 87 practitioners

The top 5 of 42 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $26,049 13% · 261 recipients
  2. Texas $20,117 10% · 302 recipients
  3. California $15,053 7% · 151 recipients
  4. Michigan $12,457 6% · 91 recipients
  5. Ohio $10,196 5% · 87 recipients

The top 5 of 44 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

115,081

Prescriptions dispensed, refills included

Drug cost

$668,772,854

Paid at the pharmacy, in all

Medicare Part D drugs matched to ORENCIA, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Orencia Clickject Abatacept Similar name 2,785 82,658 $492,474,197
Orencia Abatacept Same name 1,108 21,033 $123,851,239
Orencia Abatacept/Maltose Same name 387 11,390 $52,447,418

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 278 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Elvin Garcia Rheumatology TX 518 $2,269,585 $13
Roxabella Torres Rheumatology PR 412 $2,347,082 None on record
Jorge Mundo Rheumatology PR 357 $2,009,352 None on record
Ricardo Garcia Alemany Rheumatology FL 318 $1,380,295 $144
Jolanta Sobotka-Czarnecki Rheumatology MI 285 $1,593,064 $53

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 278 with Patron

Given in the clinic

Part B · billing code
Medicare Part B billing codes matched to ORENCIA
Billing code Providers Services Paid by Medicare
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) J0129 1,247 13,105,162 $440,285,883

Drugs given by a clinician are billed to Medicare Part B, not Part D. The product is tied to a billing code through the NDC on CMS's crosswalk, which was published for a later quarter than the payments, so a code that changed in between can be missed. Providers with fewer than 11 patients for the code are not published. Medicare's payment here is what it paid for the services, to the billing practice.

62,524 general · 914 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record